Simplex Trading
TBPH icon

Simplex Trading’s Theravance Biopharma TBPH Stock Holding History

Simplex Trading’s Portfolio TBPH Stock Details TBPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-697
Closed -$8.81K – 10056
2025
Q2 		$7K Buy
697
+591
+558% +$5.75K ﹤0.01% 7585
2025
Q1 		$0 Buy
+106
New +$986 ﹤0.01% 9660
2024
Q4 		– Sell
-323
Closed -$2K – 9601
2024
Q3 		$2K Sell
323
-11
-3% -$95 ﹤0.01% 8081
2024
Q2 		$2K Buy
+334
New +$3.01K ﹤0.01% 8356
2022
Q4 		– Sell
-48,092
Closed -$505K – 10411
2022
Q3 		$487K Buy
48,092
+44,677
+1,308% +$419K ﹤0.01% 3505
2022
Q2 		$30K Sell
3,415
-4,986
-59% -$45.9K ﹤0.01% 7166
2022
Q1 		$80K Sell
8,401
-14,664
-64% -$144K ﹤0.01% 6470
2021
Q4 		$254K Buy
23,065
+22,215
+2,614% +$194K ﹤0.01% 4824
2021
Q3 		$12K Buy
850
+100
+13% +$1.12K ﹤0.01% 8837
2021
Q2 		$10K Buy
+750
New +$14.1K ﹤0.01% 9111
2021
Q1 		– Sell
-15
Closed -$285 – 9999
2020
Q4 		$0 Buy
+15
New +$269 ﹤0.01% 9072
2020
Q3 		– Sell
-1,103
Closed -$20.7K – 8499
2020
Q2 		$23K Buy
+1,103
New +$28.3K ﹤0.01% 6115
2020
Q1 		– Sell
-6,689
Closed -$167K – 8252
2019
Q4 		$173K Buy
6,689
+1,646
+33% +$32K ﹤0.01% 3917
2019
Q3 		$98K Buy
5,043
+1,172
+30% +$23.7K ﹤0.01% 4345
2019
Q2 		$63K Buy
3,871
+3,865
+64,417% +$78.3K ﹤0.01% 4663
2019
Q1 		$0 Sell
6
-151
-96% -$3.83K ﹤0.01% 7824
2018
Q4 		$4K Buy
157
+120
+324% +$3.24K ﹤0.01% 6339
2018
Q3 		$1K Sell
37
-672
-95% -$18.3K ﹤0.01% 7230
2018
Q2 		$16K Buy
709
+677
+2,116% +$16.1K ﹤0.01% 6045
2018
Q1 		$0 Buy
+32
New +$879 ﹤0.01% 6850
2017
Q4 		– Sell
-1,177
Closed -$34.8K – 6657
2017
Q3 		$40K Sell
1,177
-2,361
-67% -$77.2K ﹤0.01% 2519
2017
Q2 		$140K Buy
+3,538
New +$136K 0.01% 1478
2016
Q4 		– Sell
-824
Closed -$25.6K – 6502
2016
Q3 		$29K Buy
824
+465
+130% +$12.9K ﹤0.01% 2598
2016
Q2 		$8K Buy
359
+356
+11,867% +$7.69K ﹤0.01% 3828
2016
Q1 		$0 Buy
+3
New +$49 ﹤0.01% 6222

Other funds holding TBPH

MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $5.91B AUM 42.42% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ICM
Irenic Capital Management New York $1.54B AUM 12.79% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Simplex Trading's TBPH Position: Q3 2025 in Review

Simplex Trading sold out of Theravance Biopharma (TBPH) in Q3 2025, closing a stake of 697 shares — an estimated $8.81K sold.

Simplex Trading first reported a position in TBPH in Q1 2016 and held it in 25 quarters. The position peaked at $487K in Q3 2022. 162 funds tracked by Wall St. Rank hold TBPH as of Q3 2025.

  • Simplex Trading reported no remaining Theravance Biopharma position as of Q3 2025 after selling out during the quarter.
  • Simplex Trading sold 697 Theravance Biopharma shares in Q3 2025, an estimated $8.81K.
  • Simplex Trading first reported a position in Theravance Biopharma in Q1 2016 and held it in 25 quarters.
  • Simplex Trading's Theravance Biopharma position peaked at $487K in Q3 2022.
  • 162 funds tracked by Wall St. Rank held Theravance Biopharma as of Q3 2025.

Based on Simplex Trading's 13F filing for Q3 2025, filed 12 Nov 2025.